Thanks to better understanding of cancer biology, the outlook for advanced lung cancer is better than it has ever been.
The prognosis and outlook for patients with stage 4 lung cancer is improving, according to Mark Socinski, M.D., executive medical director at the AdventHealth in Miami.
Recent years have brought major expansions in the understanding of tumor biology, biomarkers and genetic mutations. This has led to more personalized treatment approaches that continue to extend the lives of people with the disease.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More